Athena Sudom

1.2k total citations
21 papers, 809 citations indexed

About

Athena Sudom is a scholar working on Molecular Biology, Immunology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Athena Sudom has authored 21 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Athena Sudom's work include Hormonal Regulation and Hypertension (6 papers), NF-κB Signaling Pathways (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Athena Sudom is often cited by papers focused on Hormonal Regulation and Hypertension (6 papers), NF-κB Signaling Pathways (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Athena Sudom collaborates with scholars based in United States, Canada and Japan. Athena Sudom's co-authors include Nigel P.C. Walker, Zhulun Wang, Jay P. Powers, L. Guru Prasad, Jinsong Liu, Hughes Goldie, Louis T. J. Delbaere, Holger Wesche, Shyun Li and Xiaoshan Min and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Journal of Bacteriology.

In The Last Decade

Athena Sudom

21 papers receiving 793 citations

Peers

Athena Sudom
Evdokia Pasheva Bulgaria
Jin-Zhang Zeng China
Markus Pietsch Germany
Shu‐Ping Wang China
John F. Schindler United States
Hélène Perrier Canada
James Fossetta United States
Tadashi Teshima Japan
Andrea Olland United States
Gary L. Olson United States
Evdokia Pasheva Bulgaria
Athena Sudom
Citations per year, relative to Athena Sudom Athena Sudom (= 1×) peers Evdokia Pasheva

Countries citing papers authored by Athena Sudom

Since Specialization
Citations

This map shows the geographic impact of Athena Sudom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athena Sudom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athena Sudom more than expected).

Fields of papers citing papers by Athena Sudom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athena Sudom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athena Sudom. The network helps show where Athena Sudom may publish in the future.

Co-authorship network of co-authors of Athena Sudom

This figure shows the co-authorship network connecting the top 25 collaborators of Athena Sudom. A scholar is included among the top collaborators of Athena Sudom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athena Sudom. Athena Sudom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Jeffrey J., Aaron C. Siegmund, Wen‐Ju Bai, et al.. (2023). Imidazolone as an Amide Bioisostere in the Development of β-1,3-N-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors. Journal of Medicinal Chemistry. 66(23). 16120–16140. 10 indexed citations
2.
Estes, Bram, Athena Sudom, Danyang Gong, et al.. (2021). Next generation Fc scaffold for multispecific antibodies. iScience. 24(12). 103447–103447. 9 indexed citations
3.
Kielczewska, Agnieszka, I. D’Angelo, Tina Wang, et al.. (2021). Development of a potent high-affinity human therapeutic antibody via novel application of recombination signal sequence–based affinity maturation. Journal of Biological Chemistry. 298(2). 101533–101533. 6 indexed citations
4.
Goldstein, Rebecca, Ana Goyos, Chi-Ming Li, et al.. (2020). AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeys. Blood Advances. 4(17). 4180–4194. 37 indexed citations
5.
Sudom, Athena, Jean Danao, Xiaoshan Min, et al.. (2018). Molecular basis for the loss-of-function effects of the Alzheimer's disease–associated R47H variant of the immune receptor TREM2. Journal of Biological Chemistry. 293(32). 12634–12646. 98 indexed citations
6.
Wang, Zhulun, Daqing Sun, Sheree Johnstone, et al.. (2015). Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4. Bioorganic & Medicinal Chemistry Letters. 25(23). 5546–5550. 6 indexed citations
7.
Li, Kexue, Lawrence R. McGee, Athena Sudom, et al.. (2013). Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure–activity relationship, and co-crystal structures. Bioorganic & Medicinal Chemistry Letters. 23(5). 1238–1244. 53 indexed citations
8.
Liu, Jinsong, Athena Sudom, Xiaoshan Min, et al.. (2012). Structure of the Nuclear Factor κB-inducing Kinase (NIK) Kinase Domain Reveals a Constitutively Active Conformation. Journal of Biological Chemistry. 287(33). 27326–27334. 42 indexed citations
9.
McMinn, Dustin L., Yosup Rew, Athena Sudom, et al.. (2009). Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(5). 1446–1450. 18 indexed citations
10.
Rew, Yosup, Dustin L. McMinn, Zhulun Wang, et al.. (2009). Discovery and optimization of piperidyl benzamide derivatives as a novel class of 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(6). 1797–1801. 23 indexed citations
11.
Connors, Richard, Zhulun Wang, Martin Harrison, et al.. (2009). Identification of a PPARδ agonist with partial agonistic activity on PPARγ. Bioorganic & Medicinal Chemistry Letters. 19(13). 3550–3554. 33 indexed citations
12.
Sun, Daqing, Zhulun Wang, Mario Cardozo, et al.. (2009). Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Bioorganic & Medicinal Chemistry Letters. 19(5). 1522–1527. 16 indexed citations
13.
Tu, Hua, Jay P. Powers, Jinsong Liu, et al.. (2008). Distinctive molecular inhibition mechanisms for selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1. Bioorganic & Medicinal Chemistry. 16(19). 8922–8931. 30 indexed citations
14.
Sun, Daqing, Zhulun Wang, Juan C. Jaén, et al.. (2008). Discovery and Initial SAR of Arylsulfonylpiperazine Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1). Bioorganic & Medicinal Chemistry Letters. 18(12). 3513–3516. 28 indexed citations
15.
Hale, Clarence, Murielle M. Véniant, Zhulun Wang, et al.. (2007). Structural Characterization and Pharmacodynamic Effects of an Orally Active 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor. Chemical Biology & Drug Design. 71(1). 36–44. 26 indexed citations
16.
Wang, Zhulun, Jinsong Liu, Athena Sudom, et al.. (2006). Crystal Structures of IRAK-4 Kinase in Complex with Inhibitors: A Serine/Threonine Kinase with Tyrosine as a Gatekeeper. Structure. 14(12). 1835–1844. 116 indexed citations
17.
Delbaere, Louis T. J., et al.. (2003). Structure/function studies of phosphoryl transfer by phosphoenolpyruvate carboxykinase. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1697(1-2). 271–278. 33 indexed citations
18.
Sudom, Athena, L. Guru Prasad, Hughes Goldie, & Louis T. J. Delbaere. (2001). The phosphoryl-transfer mechanism of Escherichia coli phosphoenolpyruvate carboxykinase from the use of AlF3. Journal of Molecular Biology. 314(1). 83–92. 36 indexed citations
19.
Dimmock, Jonathan R., J. Wilson Quail, U. Pugazhenthi, et al.. (1998). Cytotoxic Activities of Mannich Bases of Chalcones and Related Compounds. Journal of Medicinal Chemistry. 41(7). 1014–1026. 152 indexed citations
20.
Dimmock, Jonathan R., Sarvesh C. Vashishtha, J. Wilson Quail, et al.. (1998). 4-(β-Arylvinyl)-3-(β-arylvinylketo)-1-ethyl-4-piperidinols and Related Compounds:  A Novel Class of Cytotoxic and Anticancer Agents. Journal of Medicinal Chemistry. 41(21). 4012–4020. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evdokia Pasheva Breakdown of academic impact, for papers by Jin-Zhang Zeng Breakdown of academic impact, for papers by Markus Pietsch Breakdown of academic impact, for papers by Shu‐Ping Wang Breakdown of academic impact, for papers by John F. Schindler Breakdown of academic impact, for papers by Hélène Perrier Breakdown of academic impact, for papers by James Fossetta Breakdown of academic impact, for papers by Tadashi Teshima Breakdown of academic impact, for papers by Andrea Olland Breakdown of academic impact, for papers by Gary L. Olson
Rankless by CCL
2026